Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News SI-BONE Inc SIBN

SI-BONE, Inc. is a medical device company dedicated to solving musculoskeletal disorders of the sacropelvic anatomy. The Company specializes in minimally invasive surgical implant systems to address sacroiliac joint dysfunction as well as address unmet clinical needs in pelvic fixation and management of pelvic fractures. The Company's products include a series of patented titanium implants and... see more

Recent & Breaking News (NDAQ:SIBN)

SI-BONE Receives Transitional Pass-Through Payment Status for iFuse Bedrock Granite(TM)

GlobeNewswire 4 days ago

SI-BONE To Report Third Quarter 2024 Financial Results on November 12, 2024

GlobeNewswire October 22, 2024

SI-BONE, Inc. Announces First-In-Patient Procedures with FDA Breakthrough Device for Pelvic Fracture Fixation

GlobeNewswire October 10, 2024

SI-BONE To Present at Morgan Stanley 22nd Annual Global Healthcare Conference on September 4, 2024

GlobeNewswire August 22, 2024

SI-BONE, Inc. Receives 510(k) Clearance and FDA Breakthrough Device Designation for Pelvic Fracture Fixation System

GlobeNewswire August 20, 2024

SI-BONE To Present at Canaccord Genuity 44th Annual Growth Conference on August 14, 2024

GlobeNewswire August 6, 2024

SI-BONE, Inc. Reports Financial Results for the Second Quarter 2024

GlobeNewswire August 5, 2024

SI-BONE To Report Second Quarter 2024 Financial Results on August 5, 2024

GlobeNewswire July 15, 2024

SI-BONE To Present at Truist Securities 2024 MedTech Conference on June 18, 2024

GlobeNewswire June 5, 2024

SI-BONE Expands Portfolio with the Launch of New Offering for the iFuse Bedrock Granite Implant System and Completes Inaugural Surgical Procedures

GlobeNewswire May 7, 2024

SI-BONE, Inc. Reports Financial Results for the First Quarter 2024

GlobeNewswire May 6, 2024

SI-BONE To Present at BofA Securities 2024 Healthcare Conference on May 14, 2024

GlobeNewswire April 29, 2024

SI-BONE To Report First Quarter 2024 Financial Results on May 6, 2024

GlobeNewswire April 15, 2024

SI-BONE to Present at Barclays 26th Annual Global Healthcare Conference on March 12, 2024

GlobeNewswire March 4, 2024

SI-BONE, Inc. Reports Record Fourth Quarter and Full Year 2023 Financial Results and Issues 2024 Guidance

GlobeNewswire February 26, 2024

SI-BONE To Report Fourth-Quarter and Full-Year 2023 Financial Results on February 26, 2024

GlobeNewswire February 5, 2024

SI-BONE, Inc. Receives FDA 510(k) Clearance for a Smaller Diameter iFuse Bedrock Granite Implant with an Expanded Indication and Application

GlobeNewswire January 30, 2024

SI-BONE Announces Preliminary Revenue for the Fourth Quarter and Full Year 2023

GlobeNewswire January 8, 2024

SI-BONE To Present at Piper Sandler 35th Annual Healthcare Conference on November 28, 2023

GlobeNewswire November 14, 2023

SI-BONE, Inc. Reports Record Financial Results for the Third Quarter 2023 and Raises Annual Guidance

GlobeNewswire November 6, 2023